Related Experiment Video
Updated: Aug 3, 2026

13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Specific activity and toxicity of hemostatic feracryl-based plaster]
Summary
A new feracryl-based plaster demonstrates strong, stable hemostatic activity across various wounds in animal models. This innovative hemostatic agent shows no local irritation, toxicity, or allergic reactions, making it a promising wound care solution.
Area of Science:
- Biomaterials Science
- Pharmacology
- Veterinary Medicine
Background:
- Hemostatic agents are crucial for managing bleeding in various clinical settings.
- Feracryl-based compounds represent a novel class of materials with potential hemostatic properties.
- Evaluating the efficacy and safety of new hemostatic agents is essential before clinical application.
Purpose of the Study:
- To evaluate the hemostatic efficacy of a novel feracryl-based plaster.
- To assess the subacute and chronic toxicity profile of the feracryl-based plaster.
- To determine the local and systemic safety of the hemostatic plaster in animal models.
Main Methods:
- Experiments were conducted on 126 rabbits and 156 guinea pigs.
- Hemostatic activity was tested on different types of wounds, including those with induced hypocoagulation.
- Subacute and chronic toxicity, local irritation, resorptive toxicity, and allergenic properties were evaluated.
Main Results:
- The feracryl-based plaster exhibited pronounced and stable hemostatic activity in various wound models.
- The plaster demonstrated efficacy even in conditions of induced hypocoagulation.
- No local irritative, resorptive toxic effects, or allergenic properties were observed.
Conclusions:
- The feracryl-based plaster is a highly effective hemostatic agent with a favorable safety profile.
- This novel plaster demonstrates significant potential for wound management and bleeding control.
- Further research may support the clinical translation of this promising hemostatic material.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

